Break even, page-2

The big news is CDC revoking the EUA for PCR tests. This is an admission of the invalidity of the test as a diagnostic tool. We all know about false positives re. Running the PCR at high cycle tresholds.
I think this bodes well for breakthrough alternatives such as Nanodx and their suppliers.
I hope some sort of a statement from the latter or even Sensera would shed light on this unique and promising market opportunity
gltah